SEC Form 4 · accession 0001645627-18-000021
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 12, 2018
Accepted (ET)
Apr 17, 2018 · 3:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 12, 2018 | P | 1,000 | $0.038 | A | 24,945,789 | D | |
| Common Stock | Apr 12, 2018 | P | 1,000 | $0.038 | A | 24,946,789 | D | |
| Common Stock | Apr 13, 2018 | P | 1,000 | $0.038 | A | 24,947,789 | D | |
| Common Stock | Apr 13, 2018 | P | 1,000 | $0.0379 | A | 24,948,789 | D | |
| Common Stock | Apr 16, 2018 | P | 1,000 | $0.033 | A | 24,949,789 | D | |
| Common Stock | Apr 16, 2018 | P | 2,000 | $0.0348 | A | 24,951,789 | D | |
| Common Stock | Apr 16, 2018 | P | 1,000 | $0.0349 | A | 24,952,789 | D | |
| Common Stock | Apr 16, 2018 | P | 1,000 | $0.035 | A | 24,953,789 | D | |
| Common Stock | Apr 16, 2018 | P | 1,000 | $0.0335 | A | 24,954,789 | D |
Table II — derivative securities
No Table II lines on this filing.